The Core Protein of the Chondroitin Sulfate Proteoglycan Phosphacan Is a High-affinity Ligand of Fibroblast Growth Factor-2 and Potentiates Its Mitogenic Activity
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Using a radioligand binding assay we have demonstrated that phosphacan, a chondroitin sulfate proteoglycan of nervous tissue that also represents the extracellular domain of a receptor-type protein tyrosine phosphatase, shows saturable, reversible, high-affinity binding (Kd approximately 6 nM) to fibroblast growth factor-2 (FGF-2). Binding was reduced by only approximately 35% following chondroitinase treatment of the proteoglycan, indicating that the interaction is mediated primarily through the core protein rather than the glycosaminoglycan chains. Immunocytochemical studies also showed an overlapping localization of FGF-2 and phosphacan in the developing central nervous system. At concentrations of 10 microg protein/ml, both native phosphacan and the core protein obtained by chondroitinase treatment potentiated the mitogenic effect of FGF-2 (5 ng/ml) on NIH/3T3 cells by 75-90%, which is nearly the same potentiation as that produced by heparin at an equivalent concentration. Although studies on the role of proteoglycans in mediating the binding and mitogenic effects of FGF-2 have previously focused on cell surface heparan sulfate, our results indicate that the core protein of a chondroitin sulfate proteoglycan may also regulate the access of FGF-2 to cell surface signaling receptors in nervous tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meyer‐Puttlitz, B., Milev, P., Junker, E., Zimmer, I., Margolis, R. U., & Margolis, R. K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052327.x · Cited by 124
Self-citation
Research works printed but not linked: 19
- Margolis, 1996, Perspect. Dev. Neurobiol., 3, 273
- Margolis, 1997, Cell Tissue Res., 290, 343, 10.1007/s004410050939 · DOI · Paper page
- Milev, 1998, J. Biol. Chem., 273, 6998, 10.1074/jbc.273.12.6998 · DOI · Paper page
- Maeda, 1996, J. Biol. Chem., 271, 21446, 10.1074/jbc.271.35.21446 · DOI · Paper page
- Burgess, 1989, Annu. Rev. Biochem., 58, 575, 10.1146/annurev.bi.58.070189.003043 · DOI · Paper page
- McKeehan, 1998, Prog. Nucleic Acid Res. Mol. Biol., 59, 135, 10.1016/S0079-6603(08)61031-4 · DOI · Paper page
- Sensenbrenner, 1993, Prog. Neurobiol., 41, 683, 10.1016/0301-0082(93)90031-M · DOI
- Baird, 1994, Curr. Opin. Neurobiol., 4, 78, 10.1016/0959-4388(94)90035-3 · DOI · Paper page
- Caday, 1990, Dev. Brain Res., 52, 241, 10.1016/0165-3806(90)90240-Y · doi:10.1016/0165-3806(90)90240-y
- Giordano, 1992, Dev. Biol., 152, 293, 10.1016/0012-1606(92)90136-5 · DOI
- Schlessinger, 1995, Cell, 83, 357, 10.1016/0092-8674(95)90112-4 · DOI · Paper page
- Rauch, 1991, J. Biol. Chem., 266, 14785, 10.1016/S0021-9258(18)98755-7 · DOI · Paper page
- Milev, 1994, J. Cell Biol., 127, 1703, 10.1083/jcb.127.6.1703 · DOI · Paper page
- Milev, 1992, J. Biotechnol., 22, 299, 10.1016/0168-1656(92)90148-3 · doi:10.1016/0168-1656(92)90148-3
- Munson, 1980, Anal. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1 · DOI · Paper page
- Meyer-Puttlitz, 1996, J. Comp. Neurol., 366, 44, 10.1002/(SICI)1096-9861(19960226)366:1<44::AID-CNE4>3.0.CO;2-K · doi:10.1002/(sici)1096-9861(19960226)366:1<44::aid-cne4>3.0.co;2-k
- Maurel, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 2512, 10.1073/pnas.91.7.2512 · DOI · Paper page
- Suzu, 1994, Blood, 83, 3113, 10.1182/blood.V83.11.3113.3113 · doi:10.1182/blood.v83.11.3113.3113
- Ruoslahti, 1991, Cell, 64, 867, 10.1016/0092-8674(91)90308-L · DOI · Paper page
Cited by
Molecular Identity of Human Outer Radial Glia during Cortical Development
Pollen, A. A., Nowakowski, T. J., Chen, J., Retallack, H., Sandoval-Espinosa, C., Nicholas, C. R., Shuga, J., Liu, S. J., Oldham, M. C., Diaz, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.004 · Cited by 908
“mote neural stem cell maturation by controlling local concentrations of fibroblast and epidermal growth factors (Barros et al., 2011; Garwood et al., 2004; Milev et al., 1998; Szklarczyk et al., 2015).”
LeX/ssea-1 Is Expressed by Adult Mouse CNS Stem Cells, Identifying Them as Nonependymal
Capela, A., & Temple, S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00835-8 · Cited by 671
Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Bandtlow, C. E., & Zimmermann, D. R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1267 · Cited by 632
Extracellular matrix of the central nervous system: from neglect to challenge
Zimmermann, D. R., & Dours-Zimmermann, M. T. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0485-9 · Cited by 465
“Notably, we also observed two- to threefold reductions, but never an abolition of the inhibitory capacity of versican V2 in stripe choice experiments after complete glycosaminoglycan-removal (Schmalfeldt et al. LTP Hippocampal long-term potentiation, EAE experimental autoimmune encephalomyelitis, PNN perineuronal net,…”
BackgroundInfluentialProteoglycans of the extracellular matrix and growth control
Kresse, H., & Schönherr, E. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10030 · Cited by 391
Metadata
- Authors
- Milev, P., Monnerie, H., Popp, S., Margolis, R. K., & Margolis, R. U.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-08
- Volume
- 273
- Issue
- 34
- Pages
- 21439-21442
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2013723454
- Cited by
- 95
- References
- 1
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 8110 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.